Eric Brey

Title: Eric Brey: Innovator in Ocular Drug Delivery Systems

Introduction

Eric Brey is a notable inventor based in San Antonio, TX (US). He has made significant contributions to the field of ocular drug delivery systems, holding 2 patents that showcase his innovative approach to medical technology.

Latest Patents

Brey's latest patents include a biodegradable extended release microsphere-hydrogel ocular drug delivery system and method. This invention features a hydrogel delivery composition that includes degradable microcapsules suspended in a thermo-responsive hydrogel. The hydrogel is designed to be responsive at physiological temperatures, changing to a more solid state upon application due to body temperatures. The composition is engineered to release one or more treatment agents over time as it degrades. Additionally, the composition can be modified to alter the structure and/or release of the treatment agent. The degradable microcapsules consist of materials such as magnesium hydroxide (Mg(OH)), bovine serum albumin (BSA), polyethylene glycol (PEG), and sucrose, which enhance the duration of release.

Career Highlights

Throughout his career, Eric Brey has focused on developing innovative solutions in the medical field. His work on biodegradable drug delivery systems reflects his commitment to improving patient care through advanced technology.

Collaborations

Brey has collaborated with notable colleagues, including Jennifer J Kang-Mieler and Victor Perez-Luna. These partnerships have contributed to the advancement of his research and the successful development of his patented technologies.

Conclusion

Eric Brey is a distinguished inventor whose work in ocular drug delivery systems has the potential to revolutionize treatment methods. His innovative patents demonstrate a commitment to enhancing medical technology for better patient outcomes.